Intercept Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €245.27M -21.4% €98.87M -179.4% 40.3% +0.80 pp -€22.50M -36.4% -9.2% +0.022 pp
    €312.02M +16.2% -€124.49M -55.3% -39.9% +0.64 pp -€35.40M -75.2% -11.3% +0.42 pp
    €268.43M +24.1% -€278.33M -17.1% -103.7% +0.51 pp -€142.62M -29.4% -53.1% +0.40 pp
    €216.33M +40.2% -€335.70M +26.5% -155.2% +0.17 pp -€202.14M -2.1% -93.4% +0.40 pp
    €154.35M +37.3% -€265.47M -14.2% -172.0% +1.0 pp -€206.50M -5.7% -133.8% +0.61 pp
    €112.42M +424.9% -€309.35M -12.7% -275.2% +14 pp -€218.91M -24.4% -194.7% +12 pp
    €21.42M +796.9% -€354.39M +82.3% -1,654.6% +65 pp -€289.61M +114.9% -1,352.1% +43 pp
    €2.39M +59.7% -€194.38M -20.1% -8,139.1% +81 pp -€134.75M +88.9% -5,642.2% -8.7 pp
    €1.50M +7.4% -€243.13M +317.8% -16,258.7% -120 pp -€71.33M +215.0% -4,770.1% -31 pp
    €1.39M -33.7% -€58.20M +55.3% -4,180.5% -24 pp -€22.64M +67.9% -1,626.6% -9.8 pp
    €2.10M +35.5% -€37.47M +242.6% -1,784.3% -11 pp -€13.49M -688.7% -642.3% -7.9 pp
    €1.55M -€10.93M -705.6% €2.29M 147.8%

    Notifications